GlassScriptPrepare for your visit
Paul Baker
Ophthalmology · Camp Hill, PA · NPI 1841417441
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,162.24
in general payments reported to CMS, 2019-2025 · $365 in 2025
The $365 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Who reported paying
General payments only, top 6 by amount.
- Genentech USA, INC. $341.43
- Regeneron Healthcare Solutions, INC. $254.74
- Abbvie INC. $125.79
- Carl Zeiss Meditec USA, INC. $102.66
- Bausch & Lomb Americas INC. $87.64
- Alcon Vision LLC $85.07
Drugs and devices associated with these payments
Eylea Hd Vabysmo Cirrus Hd-Oct Ozurdex Xipere Clareon T2 Alpha Izervay Syfovre Cimerli Yutiq Iluvien
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Paul Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/129159/paul-baker